On November 27, 2025, the Chongqing production base of Triumph Junheng for pharmaceutical medium‑borosilicate packaging materials reached a key milestone — the precise closure of the furnace crown. The accurate closure marks the substantial completion of the main furnace structure. It lays a solid foundation for ignition and commissioning of the project, and indicates that the Chongqing base of Triumph Junheng will become China’s first manufacturer that adopts international standards and realizes the large‑scale application of the “one furnace, four production lines” technology for pharmaceutical medium‑borosilicate glass.
If the medium‑borosilicate pharmaceutical glass production line is compared to a precisely operating "life system", the furnace serves as its "power hub" that supplies core driving force and directly determines the operating efficiency and output capacity of the whole production line. As the arched top of the melting furnace, the furnace crown is the most technically‑challenging and strictly‑constructed part in the whole structure. Acting as the “dome” of the furnace, its construction quality has a direct bearing on the service life, energy‑consumption indicators of the furnace and the quality of finished products.
The closure of the furnace crown was completed with precision controlled within millimeters, demonstrating the solid strength of Triumph Junheng in the field of high‑end pharmaceutical glass melting. From refined digital simulation in the early‑stage phase to real‑time dynamic monitoring during construction, all participating project teams united to overcome difficulties and delivered a high‑quality project. Every working procedure was accurately closed‑loop controlled. The steady progress of Triumph Junheng Chongqing base is strongly driving the domestic manufacturing of medium‑borosilicate pharmaceutical glass into a new stage. It helps build a secure, independent and controllable barrier for pharmaceutical packaging materials and injects powerful momentum into the high‑quality development of the pharmaceutical industry.